>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

Summary

15.34 0.31 (2.06%) 10/02/2026
Avantor, Inc. (AVTR)
Performance
Historical returns
1D
2.06%
1W
0.33%
1M
4.71%
3M
48.64%
6M
94.18%
1Y
11.40%
5Y
-61.92%
Snapshot
Key statistics
Close
15.34
Change
0.31
Change %
2.06%
Open
15.11
Day Range
14.97 – 15.38
Volume
6,149,097
Avg Vol (20d)
8,987,212
Rel Vol
0.68x
52W Range
7.27 - 16.05
vs 52W High
-4.42%
vs 52W Low
111.00%
Gap
-0.09
Market Cap
USD 10.38B
Beta
0.93
Price Chart
Advanced chartCompare
Last 730 data points are shown. To view all data, Create a free account
Bull vs Bear
6 bullish · 6 bearish points
Bullish view
  • Price targets are being raised: the last 90 days average $14.00, 51.0% above the prior three months.
  • Holds 42.9% above its 200-day average.
  • Has recovered 107.0% off the 52-week low of $7.41.
  • Outperformed the S&P 500 by 45.5% over the last quarter (+47.9% against +2.4%).
  • The Jul 2026 quarter beat on EPS by $0.02 (9.7% above consensus).
  • Revenue in the same quarter came in $81.59M ahead of consensus.
Bearish view
  • Only 3 of 13 analysts are positive — 8 sit on the fence and 2 are outright negative.
  • Gross margin slipped to 31.7% from 32.9% a year ago.
  • Full-year revenue declined 3.4% in FY2025 to $6.55B.
  • FY2025 earnings fell 174.5% to -$530.20M.
  • Already trades 25.3% above the average analyst target of $11.45.
  • The most bearish target on the street, $7.00, implies -54.4% downside; the range runs to $16.00, so the panel is far from agreed.
Both sides are generated from reported financials, consensus estimates, analyst targets and the price series — not from opinion.
Notable Price Movement
Historical returns
Oct 2
2026
$15.34 2.06%Latest
Avantor rose 2.06% to $15.34, though on light volume (0.7× the 20-day average). Roughly 1.4 points were stock-specific — the S&P 500 gained 0.74% while Healthcare peers (XLV) fell 0.01% alongside it. Shares closed near the session high (90% of the day's range) and reclaimed their 20-day moving average. The move added $209.9M of market value and left the stock 3.3% below its 52-week high.
Sep 24
2026
$15.38 4.20%
Avantor rose 4.20% to $15.38, its biggest one-day gain in 1 month. This was largely stock-specific: the S&P 500 fell 0.08% while Healthcare peers (XLV) rose 0.63% that session, leaving about 3.6 points of the move unexplained by its sector. Shares closed near the session high (93% of the day's range) and reclaimed their 20-day moving average. The move added $419.9M of market value.
Sep 17
2026
$15.86 1.60%52W High
Avantor rose 1.60% to $15.86. The move was broadly in line with the wider market — the S&P 500 gained 1.39% while Healthcare peers (XLV) rose 0.62% the same session — so little of it was company-specific. Shares opened with a 1.28% gap up, set a 52-week closing high and marked a 4th consecutive advance. The move added $169.3M of market value.
Sep 16
2026
$15.61 1.10%52W High
Avantor rose 1.10% to $15.61, on 1.5× average volume. This was largely stock-specific: the S&P 500 fell 0.44% while Healthcare peers (XLV) rose 0.07% that session, leaving about 1.0 points of the move unexplained by its sector. Shares set a 52-week closing high and marked a 3rd consecutive advance. The move added $115.1M of market value.
Sep 8
2026
$15.25 1.87%
Avantor rose 1.87% to $15.25, on 2.0× average volume. This was largely stock-specific: the S&P 500 fell 0.55% while Healthcare peers (XLV) fell 2.52% that session, leaving about 2.4 points of the move unexplained by the market after adjusting for a 0.93 beta. Shares opened with a 0.94% gap down and reversed through the session. The move added $189.6M of market value.
Sep 3
2026
$15.19 3.69%
Avantor rose 3.69% to $15.19, its biggest one-day gain in 2 weeks, on 1.5× average volume. Roughly 2.7 points were stock-specific — the S&P 500 gained 1.05% while Healthcare peers (XLV) rose 0.18% alongside it. Shares opened with a 0.89% gap up and closed near the session high (98% of the day's range). The move added $365.7M of market value.
Computed from adjusted closes over the last 22 sessions; attribution vs SPY and XLV.
Price Performance
All periods
PeriodPeriod LowPeriod HighPerformance
1-Month14.22 +7.88%
on 09/02/26
Open 14.65
16.05 -4.42%
on 09/17/26
+0.69 (+4.71%)
since 09/02/26
3-Month9.73 +57.66%
on 07/09/26
Open 10.37
16.05 -4.42%
on 09/17/26
+4.97 (+47.93%)
since 07/06/26
6-Month7.42 +106.74%
on 05/20/26
Open 7.90
16.05 -4.42%
on 09/17/26
+7.44 (+94.18%)
since 04/02/26
YTD7.27 +111.00%
on 03/27/26
Open 11.46
16.05 -4.42%
on 09/17/26
+3.88 (+33.86%)
since 01/02/26
52-Week7.27 +111.00%
on 03/27/26
Open 13.67
16.05 -4.42%
on 09/17/26
+1.67 (+12.22%)
since 10/01/25
5-Year7.27 +111.00%
on 03/27/26
Open 44.01
44.06 -65.18%
on 09/24/21
-28.67 (-65.14%)
since 09/24/21
New Highs
Historical highs
5-Day
1×
0.00% from peak
1-Month
4×
-3.28% from peak
3-Month
17×
-3.28% from peak
6-Month
32×
-3.28% from peak
YTD
14×
-3.28% from peak
52-Week
7×
-3.28% from peak
2-Year
0×
-40.70% from peak
3-Year
25×
-44.62% from peak
5-Year
2×
-63.60% from peak
10-Year
n/a
not enough history
Financial SnapshotFY 2025
Full financials
Revenue
USD 6.55B
-3.4% YoY
Net Income
-USD 530.20M
-174.5% YoY
EPS
-0.78
-174.3% YoY
Gross Margin
32.7%
Operating Margin
-3.8%
Net Margin
-8.1%
EBITDA
USD 138.70M
Free Cash Flow
USD 495.00M
7.6% margin
ROE
-9.5%
ROA
-4.5%
Debt / Equity
0.71x
net debt USD 3.58B
Cash & Equiv.
USD 365.40M
News
All news
10/01 06:05 ET · prnewswire.com
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
RADNOR, Pa., Oct. 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2026 financial results before the market opens...
09/21 10:41 ET · zacks.com
Are Medical Stocks Lagging Avantor (AVTR) This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
09/21 06:05 ET · prnewswire.com
Avantor appoints new Chief Financial Officer
RADNOR, Pa., Sept. 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective...
09/18 10:31 ET · zacks.com
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
AVTR expands its RIM single-use bioprocessing portfolio across APAC, boosting access to locally made solutions and supporting its bioprocessing growth push.
09/16 12:41 ET · zacks.com
Here's Why You Should Add Avantor Stock to Your Portfolio for Now
AVTR's strong Q2 results, improving orders and raised 2026 outlook support growth prospects, though BMP weakness and uneven demand remain concerns.
09/04 10:56 ET · zacks.com
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
08/28 12:36 ET · zacks.com
Why Is Avantor (AVTR) Up 5.4% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?
08/25 12:46 ET · zacks.com
Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?
AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.

Market News ×
Loading news…